Article

Immunohistochemical assays for bladder cancer molecular subtyping: Optimizing parsimony and performance using Lund taxonomy

2021-08-09

Abstract excerpt

Transcriptomic and proteomic profiling reliably classifies bladder cancers into luminal and basal molecular subtypes. Based on their prognostic and predictive associations, these subtypes may improve clinical management of bladder cancers. However, the complexity of published subtyping algorithms has limited their translation into practice. Here we optimize and validate compact subtyping algorithms based on the Lu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 29019917-e74a-5529-b98c-44db1471a68f
DOI: 10.1101/2021.08.06.455345

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical assays for bladder cancer molecular subtyping: Optimizing parsimony and performance using Lund taxonomyDOI 10.1101/2021.08.06.455345Read

Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy ClassifiersSemantic proximity Read

International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4Semantic proximity Read

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder CancerSemantic proximity Read

Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16Semantic proximity Read

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.Semantic proximity Read

Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.Semantic proximity Read

Update on bladder cancer molecular subtypesSemantic proximity Read

The consensus molecular classification of muscle-invasive bladder cancerSemantic proximity Read

Molecular subtyping of invasive bladder cancer: time to divide and rule?Semantic proximity Read

A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testingSemantic proximity Read

The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back againSemantic proximity Read

Verification of molecular subtyping of bladder cancer in the GUSTO clinical trialSemantic proximity Read